Mirabella Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mirabella Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,043	Closed	-$597K	–	935
2025 Q4	$597K	Buy	+10,043	New	+$547K	0.06%	207
2024 Q3	–	Sell	-2,487	Closed	-$205K	–	197
2024 Q2	$205K	Buy	+2,487	New	+$207K	0.01%	393
2023 Q2	–	Sell	-25,652	Closed	-$1.33M	–	499
2023 Q1	$1.33M	Sell	25,652 -8,232	-24%	-$853K	0.2%	94
2022 Q4	$3.51M	Buy	33,884 +30,940	+1,051%	+$2.9M	0.31%	57
2022 Q3	$250K	Sell	2,944 -3,416	-54%	-$304K	0.03%	249
2022 Q2	$527K	Buy	+6,360	New	+$506K	0.05%	238
2021 Q1	–	Sell	-5,257	Closed	-$461K	–	290
2020 Q4	$461K	Buy	+5,257	New	+$417K	0.06%	177

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirabella Financial Services's BMRN Position: Q1 2026 in Review

Mirabella Financial Services sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 10,043 shares — an estimated $597K sold.

Mirabella Financial Services first reported a position in BMRN in Q4 2020 and held it in 7 quarters. The position peaked at $3.51M in Q4 2022. 559 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Mirabella Financial Services reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Mirabella Financial Services sold 10,043 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $597K.
Mirabella Financial Services first reported a position in BioMarin Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Mirabella Financial Services's BioMarin Pharmaceuticals position peaked at $3.51M in Q4 2022.
559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.